|
Market Closed -
Nasdaq
01:30:00 04/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 2.140 USD | 0.00% |
|
-0.93% | -38.15% |
| 25/08 | Grace Therapeutics Files for Resale of Up to 4.8 Million Shares | MT |
| 14/08 | Grace Therapeutics, Inc. Reports Impairment charges for the First Quarter Ended June 30, 2026 | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| GRCE | Delayed | |
CBOE
| GRCE | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 2.2 | 3.33 | 3.18 |
| Spread/Res. | -2.73% | -35.74% | -32.70% |
| Spread/Supp. | +3.38% | +3.38% | +2.88% |
| Support | 2.07 | 2.07 | 2.08 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- GRCE Stock
- Charts Grace Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
